1. ZANUBRUTINIB PLUS OBINUTUZUMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) OR RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL). (12th June 2019) Authors: Tam, C.S.; Quach, H.; Nicol, A.; Badoux, X.; Rose, H.; Prince, H.M.; Leahy, M.F.; Eek, R.; Wickham, N.; Patil, S.S.; Huang, J.; Prathikanti, R.; Wang, L.; Reed, W.; Flinn, I.W. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAFETY AND ACTIVITY OF THE HIGHLY SPECIFIC BTK INHIBITOR, BGB‐3111 PLUS OBINUTUZUMAB IN PATIENTS (PTS) WITH FOLLICULAR LYMPHOMA (FL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). (June 2017) Authors: Tam, C.S.; Quach, H.; Nicol, A.; Badoux, X.; Rose, H.; Prince, H.; Leahy, M.F.; Eek, R.; Wickham, N.; Patil, S.; Huang, J.; Zhang, X.; Wang, L.; Hedrick, E.; Novotny, W.; Flinn, I. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score. Issue 213 (May 2022) Authors: Alexander, M.; Harris, S.J.; Underhill, C.; Torres, J.; Sharma, S.; Lee, N.; Wong, H.; Eek, R.; Michael, M.; Tie, J.; Rogers, J.; Heriot, A.; Ball, D.; MacManus, M.; Wolfe, R.; Solomon, B.; Burbury, K. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. Issue 213 (May 2022) Authors: Alexander, M.; Harris, S.J.; Underhill, C.; Torres, J.; Sharma, S.; Lee, N.; Wong, H.; Eek, R.; Michael, M.; Tie, J.; Rogers, J.; Heriot, A.; Ball, D.; MacManus, M.; Wolfe, R.; Solomon, B.; Burbury, K. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY. (17th June 2021) Authors: Wang, M.; Rule, S.; Zinzani, P. L.; Goy, A.; Casasnovas, O.; Smith, S. D.; Damaj, G.; Doorduijn, J. K.; Lamy, T.; Morschhauser, F.; Panizo, C.; Shah, B.; Davies, A.; Eek, R.; Dupuis, J.; Jacobsen, E.; Kater, A. P.; Le Gouill, S.; Oberic, L.; Robak, T. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12 DIRECT STUDY BASED ON TROUGH LEVELS MINIMISE TOXICITY AND PRESERVE EFFICACY. (23rd June 2022) Authors: Yeung, D.; Grigg, A.; Shanmuganathan, N.; Soltenbeck, A.; White, D.; Branford, S.; Viiala, N.; Rowlings, P.; Mills, A.; Shortt, J.; Tiley, C.; Ross, D.; Kipp, D.; Harrup, R.; Cunningham, I.; Kwan, J.; Eek, R.; Mutsando, H.; Tan, K.-S.; Burbury, K. Other Names: other. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB. (23rd June 2022) Authors: Le Gouill, S.; Długosz-Danecka, M.; Rule, S.; Luigi Zinzani, P.; Goy, A.; Smith, S. D.; Doorduijn, J. K.; Panizo, C.; Shah, B.; Davies, A.; Eek, R.; Jacobsen, E.; Kater, A. P.; Robak, T.; Jain, P.; Calvo, R.; Yang, H.; Wang, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FEASIBILITY OF THE ELECTRONIC RAPID FITNESS ASSESSMENT (ERFA) IN AN AUSTRALIAN REGIONAL CANCER CENTER. (November 2019) Authors: Steer, C.B.; Alidina, A.; Webb, N.; Long, D.; Forbes, D.; Underhill, C.; Eek, R.; Clarke, K.; Shahrokni, A. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 13 THE ADDITION OF LENALIDOMIDE TO AZACITIDINE ACHIEVES HIGHER RESPONSES BUT NO IMPROVEMENT IN TWELVE MONTH CLINICAL BENEFIT OR PFS; MAIN ANALYSIS AUSTRALIAN ALLG MDS4 TRIAL. (April 2015) Authors: Kenealy, M.; Benson, W.; Stevenson, W.; Eek, R.; Zantomio, D.; Cunningham, I.; Hiwase, D.; Cowan, L.; Vlachos, S.; Zannino, D.; Seymour, J.F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗